Home/Pipeline/NaPPS R&D

NaPPS R&D

Various (Vascular/Inflammatory)

ResearchActive

Key Facts

Indication
Various (Vascular/Inflammatory)
Phase
Research
Status
Active
Company

About bene-Arzneimittel

bene-Arzneimittel is a well-established, private German pharmaceutical company with a 70+ year legacy originating from its founder's synthesis of sodium pentosan polysulfate (NaPPS). Its business is built on a dual foundation: a portfolio of trusted, classic OTC products like ben-u-ron® for pain and fever, and a proprietary platform around the unique active substance NaPPS, which has led to approved prescription drugs. With approximately 120 employees, the company maintains full control over its supply chain through a subsidiary for API manufacturing and emphasizes quality production in Germany, while pursuing international expansion and new product development.

View full company profile